Mast Cell Activation Syndrome (MCAS) is a condition that can be frustrating for patients and clinicians alike. Symptoms are real, often debilitating, and can affect multiple organ systems, yet standard testing is frequently normal. As allergists and immunologists, our role is to carefully separate true mast cell disease from look-alike conditions and arrive at a diagnosis using a structured, evidence-based approach.
What Are Mast Cells and Why Do They Matter?
Mast cells are immune cells involved in allergic and inflammatory responses. When activated, they release chemical mediators such as histamine, tryptase, prostaglandins, and leukotrienes. These mediators are responsible for classic allergy symptoms, hives, flushing, wheezing—but can also cause gastrointestinal, cardiovascular, and neurologic complaints.
In MCAS, mast cells are overactive, releasing mediators inappropriately and repeatedly, even without a clear allergic trigger.
Step 1: Recognizing the Right Symptom Pattern
The first and most important step in diagnosing MCAS is clinical suspicion.
We look for:
Recurrent, episodic symptoms
Involvement of two or more organ systems
Common symptoms include:
Skin: flushing, itching, hives, swelling
GI: abdominal pain, diarrhea, nausea, reflux
Respiratory: wheezing, throat tightness, shortness of breath
Cardiovascular: lightheadedness, tachycardia, low blood pressure
Neurologic: brain fog, headaches, fatigue
A key feature is that symptoms often flare suddenly, may resemble allergic reactions, and improve between episodes.
Step 2: Excluding Other Conditions
MCAS is a diagnosis of exclusion. Before labeling someone with MCAS, we must rule out conditions that can mimic it, such as:
IgE-mediated food or drug allergies
Chronic spontaneous urticaria
Asthma or vocal cord dysfunction
Carcinoid syndrome
Pheochromocytoma
Hereditary angioedema
Autoimmune or gastrointestinal disorders
A careful history, physical exam, and targeted testing are critical here.
Step 3: Objective Evidence of Mast Cell Activation
To diagnose MCAS, we need biochemical proof that mast cells are releasing mediators during symptoms.
The Most Important Test: Serum Tryptase
Tryptase should be measured during a flare (ideally within 1–4 hours of symptoms)
A baseline tryptase should also be obtained when the patient is well
A rise that meets the following criterion supports mast cell activation:
Acute tryptase ≥ (baseline × 1.2) + 2 ng/mL
Importantly:
Many MCAS patients have normal baseline tryptase
A normal tryptase does not rule out MCAS
Additional Mediator Testing
Depending on symptoms, we may also check:
24-hour urine N-methylhistamine
24-hour urine prostaglandin D2 or 11-β-PGF2α
24-hour urine leukotriene E4
These tests must be collected properly and, ideally, during or shortly after symptom flares.
Step 4: Response to Mast Cell–Directed Treatment
The final diagnostic criterion is clinical response to therapy.
We look for improvement with medications such as:
H1 antihistamines (e.g., cetirizine, fexofenadine)
H2 blockers (e.g., famotidine)
Leukotriene inhibitors (e.g., montelukast)
Mast cell stabilizers (e.g., cromolyn sodium)
In select cases, aspirin or biologics
If symptoms significantly improve with mast cell–targeted treatment, this supports the diagnosis.
Diagnostic Criteria Summary
MCAS is diagnosed when all three of the following are present:
Typical symptoms involving ≥2 organ systems
Objective evidence of mast cell mediator release
Response to mast cell–directed therapy
Missing any one of these should prompt re-evaluation.
MCAS vs. Mastocytosis: Not the Same Thing
It’s important to distinguish MCAS from systemic mastocytosis:
Mastocytosis involves increased numbers of mast cells
MCAS involves normally distributed but overactive mast cells
Most MCAS patients do not have elevated baseline tryptase or bone marrow involvement.
Why MCAS Is Often Missed
MCAS can be overlooked because:
Labs are often normal between flares
Symptoms overlap with many common conditions
Testing requires precise timing
There is still limited awareness outside allergy/immunology
This is why evaluation by an allergist familiar with mast cell disorders is essential.
Final Thoughts
MCAS is real, complex, and treatable—but only when diagnosed thoughtfully. A careful history, exclusion of mimicking conditions, targeted mediator testing, and assessment of treatment response are all crucial. When approached systematically, we can help patients finally make sense of years of unexplained symptoms and significantly improve their quality of life.
If you suspect MCAS, seek evaluation with a board-certified allergist/immunologist experienced in mast cell disorders.